Urology · Springfield, OR
NPI
1518978204
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2400 Hartman Ln
Springfield, OR, 97477
Phone (541) 334-3350
Groups this clinician bills Medicare through
Medicare paid, 2024
$214K
9,469 services
Medicare patients, 2024
376
Average age 76
Drug cost, 2024
$12.3M
2,378 prescriptions
Company payments, 2025
$155K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bryan A Mehlhaff was code J0897 (injection, denosumab, 1 mg), 5,460 times for 28 patients. In total Bryan A Mehlhaff billed 9,469 services in 71 codes, and Medicare paid $214K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 5,460 | 28 | $20.28 | $111K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2,312 | 23 | $0.10 | $240 |
| 99214 Office E&M - Established | Office | 250 | 159 | $84.92 | $21K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 232 | 165 | $10.61 | $2,462 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 186 | 22 | $140.77 | $26K |
| 99213 Office E&M - Established | Office | 119 | 106 | $59.38 | $7,066 |
| 51798 Ultrasound - Nonspecific | Office | 96 | 86 | $7.21 | $692 |
| 81002 Clinical Chemistry | Office | 87 | 72 | $3.41 | $297 |
| 52000 Cystourethroscopy | Facility | 86 | 78 | $56.93 | $4,896 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 60 | 34 | $46.94 | $2,816 |
| 96372 Injection Administration | Office | 58 | 28 | $11.02 | $639 |
| 52000 Cystourethroscopy | Office | 42 | 38 | $142.53 | $5,986 |
| 81000 Clinical Chemistry | Office | 32 | 30 | $3.94 | $126 |
| 96402 Chemotherapy Administration | Office | 31 | 22 | $27.08 | $840 |
| 55700 Other Organ Systems | Facility | 20 | 20 | $91.50 | $1,830 |
By year: 2022 $334K for 16,776 services; 2023 $244K for 10,758 services; 2024 $214K for 9,469 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 87 | 72 | $3.41 | $297 |
| 81000 Clinical Chemistry | 32 | 30 | $3.94 | $126 |
Medicare prescription drug claims, 2024
In 2024, the drug Bryan A Mehlhaff prescribed most often to Medicare patients was Finasteride, with 457 prescriptions and refills. In total Bryan A Mehlhaff wrote 2,378 Medicare prescriptions that cost $12.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Finasteride Generic | 457 | 1,254 | 148 | $6,520 |
| Orgovyx Relugolix | 302 | 302 | 47 | $778K |
| Nubeqa Darolutamide | 261 | 261 | 38 | $3.4M |
| Erleada Apalutamide | 255 | 255 | 31 | $3.6M |
| Tamsulosin Hcl Generic | 238 | 637 | 90 | $4,250 |
| Xtandi Enzalutamide | 221 | 221 | 31 | $3.0M |
| Prednisone Generic | 130 | 150 | 25 | $879 |
| Yonsa Abiraterone Acet,submicronized | 99 | 99 | 14 | $989K |
| Abiraterone Acetate Generic | 58 | 58 | 11 | $34K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 57 | 147 | 19 | $1,837 |
| Oxycodone Hcl Generic | 54 | 54 | 46 | $135 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 33 | 73 | 11 | $801 |
| Lynparza Olaparib | 16 | 16 | Under 11 | $265K |
| Potassium Citrate Er Potassium Citrate | 16 | 40 | Under 11 | $1,395 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 16 | 16 | 15 | $99.82 |
Brand drugs: 1,182 claims; generic drugs: 1,196 claims; opioid claims: 66.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bryan A Mehlhaff $155K ($123K in general payments such as food, travel and fees and $31K for research) from 21 companies. The largest payer was Dendreon Pharmaceuticals LLC with $50K.
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 19 | $50K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 19 | $29K |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 15 | $26K |
| Novartis Pharmaceuticals Corporation NVS | 16 | $18K |
| Janssen Biotech, Inc. JNJ | 26 | $14K |
| Pfizer Inc. PFE | 11 | $8,440 |
| Janssen Global Services, LLC JNJ | 10 | $2,821 |
| AstraZeneca UK Limited AZN | 1 | $2,240 |
| Ferring Pharmaceuticals Inc. | 2 | $1,685 |
| Janssen Pharmaceuticals, Inc JNJ | 2 | $1,321 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.